Biosensors for environmental pollutants and food contaminants

This review article provides an overview of the most recent literature on biosensors for environmental pollutants and food contaminants. Due to the large number of publications, only papers published between 2000 and January 2003 were considered. Also, while not all of the published literature could be reviewed here, over 200 references are cited to provide a good overview of research undertaken in the last two years. Older publications are covered by a number of earlier review articles. This article provides an introduction into the field including specific consideration of the application areas, describes the typical biosensor assay format used, and is subsequently structured according to the biorecognition elements used (i.e., nucleic acids, enzymes, whole cells, tissue and whole organisms, antibodies and receptors, and biomimetic materials). In addition, a section on microbiosensing systems is provided. Since only very few microbiosensors with applications in environmental and food systems have been published, enabling technology is also covered in this article.Abbreviations BOD biological oxygen demand - cfu colony forming units - DNP dinitrophenol - GFP green fluorescent protein - NASBA nucleic acid sequence-based amplification - PCR polymerase chain reaction - ppt parts per trillion - QCM quartz crystal microbalance - SPR surface plasmon resonance     

Application of Task-specific Ionic Liquids for Intensified Separations

Summary. Ionic liquids offer tremendous opportunities to intensify reactions and separations in process technologies by tuning their physical and chemical properties. Several ionic liquids are suitable for the separation of aromatic and aliphatic hydrocarbons. CO₂ absorption behavior was influenced by the functionalized chains appended to the room temperature ionic liquid (RTIL) cation. Ionic liquids seem able to combine the chemical features of amine solutions with the characteristic advantages of the physical solvents used for CO₂ absorption.     

Formation and Crystallization Behavior of Gels in the Na2O-SiO2-TiO2-ZrO2 System

SiO₂-TiO₂-ZrO₂ and 5Na₂O·95(SiO₂ + TiO₂ + ZrO₂) gels were synthesized and role of Na₂O in gel formation and crystallization behavior of gels were studied. From Si(OC₂H₅)₄, Ti(iso-OC₃H₇)₄, Zr(n-OC₃H₇)₄ and NaOCH₃ solutions in EtOH without H₂O, transparent and opaque gels were obtained. Opaque bulk gels, rich in TiO₂ or ZrO₂ composition in Na₂O containing SiO₂-TiO₂-ZrO₂ system, contain agglomerated spherical particles of diameter small <10 m, in contrast with opaque gels having large particles <30 m in alkali-free SiO₂-TiO₂-ZrO₂ system. Crystallization temperature (Tc) was measured by DTA on dried gels. Compared with the alkali-free SiO₂-TiO₂-ZrO₂ gels, 5 mol% Na₂O containing gels gave lower Tc in SiO₂ rich compositions and higher in TiO₂ rich or ZrO₂ rich compositions.     

A synthesis, including asymmetric synthesis, of α-quaternary α-amino aldehydes from ketones and chloromethyl p-tolyl sulfoxide via sulfinylaziridines

Treatment of 1-chlorovinyl p-tolyl sulfoxides, prepared from ketones and chloromethyl p-tolyl sulfoxide, with N-lithio arylamines resulted in the formation of sulfinylaziridines in good to high yields. The sulfinylaziridines were treated with N-lithio aniline or N-lithio p-chloroaniline to afford α-quaternary α-amino aldehydes in good yields. From α-quaternary α-amino aldehydes, α-quaternary α-amino acid esters and β-quaternary β-amino alcohols were obtained. When optically active chloromethyl p-tolyl sulfoxide was used in this procedure, a method for the synthesis of optically active α-quaternary α-amino aldehydes was realized. The reaction mechanism, including asymmetric induction, for the formation of the sulfinylaziridines is described.     

Stereoselective Synthesis of Isomers of the Naturally Occurring 13-Hydroxy-2,4,9-tetradecatrienoic Acid. Part II [1]

The stereoselective syntheses of four unsaturated hydroxy fatty acids 13S,2E,4E,9E)- 13-hydroxy-2,4,9-tetradecatrienoic acid, (13S,9Z,11E)-13-hydroxy-9,11-tetradecadienoic acid, (13S,9E, 11E)-13-hydroxy-9,11-tetradecadienoic acid, and (13S,2E,4E,9E)-13-hydroxy-2,4,9,11-tetradecatrienoic acid, are described. Wittig reactions, regioselective oxidation of dialcohol 3, and diastereomerization were used.     

Parathyroid hormone and bone mineral content in male and female patients receiving hemodialysis

Relative bone mineral content in the lumbar spine was measured by phantom B-MAs with the apparatus of computerized tomography in order to study the relationships between bone mineral content with age and parathyroid hormone in sera of randomized out- and in-patients and the hemodialysis patients. There exists a significant difference between male and female in the loss of bone mineral content of three groups.     

Clinical evaluation of osteocalcin in sera of the patients with neoplasms of bone

The clinical significance of osteocalcin in sera of bone tumors were measured in sera of various kinds of bone tumors. The levels of osteocalcin were higher in bone tumors than those in normal subjects. Serum osteocalcin levels in hypercalcemic groups of bone metastasis and myeloma showed a remarkable increase in a parallelism with serum ALP and LDH levels. These results suggested to be directly or indirectly activated on osteoblast by bone tumors and to be synthesized osteocalcin in osteoblast.     

The study in the relationship between serum calcium and serum parathyroid hormone (PTH) by employing the various kits of PTH assay

In order to evaluate the influences of serum PTH assay in the various concentrations of serum calcium, we divided into three groups which serum calcium had below 8.0 mg/dl, 8.2 mg/dl to 9.8 mg/dl and above 10.0 mg/dl at random samples and assayed PTH in serum sample, using various kits of PTH assay obtained from commercial sources. Our results suggested that the measurement of serum PTH influenced by the concentration of serum calcium and therefore, should be taken an attention of serum calcium in each sample.     

Solvent effect on the radical polymerization of di-n-butyl itaconate

Solvent effect on the polymerization of di-n-butyl itaconate (DBI) with dimethyl azobisisobutyrate (MAIB) was investigated at 50 and 61°C. The solvents used were found to affect significantly the polymerization. The polymerization rate (R_p) and the molecular weight of the resulting polymer are lower in more polar solvents. The initiation rate (R_i) by MAIB, however, shows a trend of being rather higher in polar solvents. The stationary state concentration of propagating poly(DBI) radical was determined by ESR in seven solvents. The rate constants of propagation (k_p) and termination (k_t) were evaluated by using R_p, R_i, and the polymer radical concentration observed. The k_p value decreases fairly with increasing polarity of the solvent used, whereas k_t is not so influenced by the solvents. The solvent effect on k_p is explained in terms of a difference in the environment around the terminal radical center of the growing chain. Copolymerization of DBI with styrene (St) was also examined in three solvents with different physical properties. The poly(DBI) radical shows a lower reactivity toward St in a more polar solvent.     

A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterised by selective neuronal death in the brain stem and spinal cord. The cause is unknown, but an increasing amount of evidence has firmly certified that neuroinflammation plays a key role in ALS pathogenesis. Neuroinflammation is a pathological hallmark of several neurodegenerative disorders and has been implicated as driver of disease progression. Here, we describe a treatment study demonstrating the therapeutic potential of a tandem version of the well-known all-d-peptide RD2 (RD2RD2) in a transgenic mouse model of ALS (SOD1*G93A). Mice were treated intraperitoneally for four weeks with RD2RD2 vs. placebo. SOD1*G93A mice were tested longitudinally during treatment in various behavioural and motor coordination tests. Brain and spinal cord samples were investigated immunohistochemically for gliosis and neurodegeneration. RD2RD2 treatment in SOD1*G93A mice resulted not only in a reduction of activated astrocytes and microglia in both the brain stem and lumbar spinal cord, but also in a rescue of neurons in the motor cortex. RD2RD2 treatment was able to slow progression of the disease phenotype, especially the motor deficits, to an extent that during the four weeks treatment duration, no significant progression was observed in any of the motor experiments. Based on the presented results, we conclude that RD2RD2 is a potential therapeutic candidate against ALS.